|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-5-1
|
|
pubmed:abstractText |
Chlorhexidine (CHX) is widely accepted as the most effective product in the control of supragingival plaque. It is available in different delivery devices. The aim of this study was to test whether 0.12% CHX spray was as effective as 0.2% CHX spray and 0.2% CHX mouthwash in a 3-day "de novo" plaque formation model.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
D
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-3492
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
899-904
|
|
pubmed:meshHeading |
pubmed-meshheading:17470024-Adolescent,
pubmed-meshheading:17470024-Adult,
pubmed-meshheading:17470024-Aerosols,
pubmed-meshheading:17470024-Chlorhexidine,
pubmed-meshheading:17470024-Dental Plaque,
pubmed-meshheading:17470024-Dental Plaque Index,
pubmed-meshheading:17470024-Drug Delivery Systems,
pubmed-meshheading:17470024-Female,
pubmed-meshheading:17470024-Humans,
pubmed-meshheading:17470024-Male,
pubmed-meshheading:17470024-Mouthwashes,
pubmed-meshheading:17470024-Reference Values,
pubmed-meshheading:17470024-Statistics, Nonparametric,
pubmed-meshheading:17470024-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Inhibition of "de novo" plaque formation with 0.12% chlorhexidine spray compared to 0.2% spray and 0.2% chlorhexidine mouthwash.
|
|
pubmed:affiliation |
Department of Periodontology, Academic Center for Dentistry Amsterdam, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
